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Abstract: The purpose of this study was to investigate whether photocatalytic TiO2 nanoparticles have adjuvant effect, when
administered in combination with ovalbumin (OVA) in mice. Mice were immunized via intraperitoneal injections of OVA,
OVA + TiO2 or OVA + Al(OH)3 and challenged with aerosols of OVA. At the end of the study, serum was analysed for
content of OVA-specific IgE, IgG1 and IgG2a antibodies, and the bronchoalveolar lavage fluid (BALF) was analysed for
content of inflammatory cells and levels of interleukin (IL)-4, IL-5, IL-10 and interferon-c.T h eT i O 2 particles promoted a
Th2 dominant immune response with high levels of OVA-specific IgE and IgG1 in serum and influx of eosinophils, neutro-
phils and lymphocytes in BALF. The TiO2 particles induced a significantly higher level of OVA-specific IgE than the standard
adjuvant Al(OH)3. However, the two substances were comparable regarding the level of eosinophilic inflammation and inter-
leukins present in BALF.
Epidemiological as well as laboratory studies have provided
evidence that exposure to ambient particulate matter is asso-
ciated with different health effects, including airway inflam-
mation [1,2], allergic sensitization [3–7] and exacerbation of
asthma [8,9]. Thus, diesel exhaust particles are able to
increase sensitization against allergens both in animals and
humans [6,7,10]. Recently man-made nanomaterials, includ-
ing single-walled and multi-walled carbon nanotubes as well
as latex nanoparticles, have been shown to promote allergic
sensitization [11], allergic lung inflammation [12,13] and
airway fibrosis [14].
In contrast to e.g. diesel exhaust particles and carbon
nanotubes, titanium dioxide (TiO2) particles are generally
accepted to be low-toxic to humans as well as animals
[15–17]. The presumed low toxicity of TiO2 is reflected in the
wide use of this compound, for example as a pigment in
paints, food, medicine and sunscreens [18–20]. Micrometer-
sized TiO2 particles showed no adjuvant effect when admin-
istered to mice in combination with ovalbumin (OVA) [21].
For many substances, including TiO2,ar e d u c t i o no f
particle size is associated with increased pro-inflammatory
properties [22] and oxidative damage in human bronchial
epithelial cell line [23]. With the development of nanotech-
nology and manufacturing of products containing nanoparti-
cles, knowledge of the role of particle size on the toxicity is
of increasing importance. Only one previous study [21] has
investigated the effect of nano-sized TiO2 on the immune
response to simultaneously administered allergen, but very
fine particles of widely different composition possessed adju-
vant effect in a mouse model using OVA as model allergen
[24]. Also, adjuvant effect of particles on allergic sensitization
has been shown to increase with decreasing particle size
[21,25].
Some of the newly marketed ‘nano’ household spray prod-
ucts with self-cleaning properties contain nano-sized photo-
catalytic TiO2, why human airway exposures to such
particles may be increasing. Similarly, paints are deliberately
added nanoparticulate TiO2 to obtain improved properties
and self-cleaning effects. Numerous other products may also
contain TiO2 nanoparticles. The present study aimed to
investigate whether nano-sized photocatalytic TiO2 possess
adjuvant effect and promote allergic sensitization when
administered in combination with OVA in mice.
Materials and Methods
Animals. Inbred female BALB⁄cJ mice aged 5–6 weeks were pur-
chased from Taconic M&B, Ry, Denmark, and were housed as
described previously [26]. Treatment of the animals followed proce-
dures approved by The Animal Experiment Inspectorate, Denmark.
Chemicals. Chicken egg OVA (CAS 9006-59-1) was grade V (pur-
ity ‡ 98%) from Sigma-Aldrich, St. Louis, MO, USA. The Al(OH)3
adjuvant was from Alhydrogel, Brenntag Biosector, Frederikssund,
Denmark.
The TiO2 was VP Disp. W 2730 X from Degussa AG (Frankfurt
am Main, Germany), now Evonik Industries, which is a 30 wt%
dispersion of fumed TiO2. The hydrodynamic particle number size
distribution of the TiO2 particles were determined by photon correla-
tion spectroscopy using a Dynamic Laser Scatter (DLS) Zetasizer
nano ZS (Malvern Inc., Malvern, UK) equipped with a 4 mW,
633 nm He-Ne Class I Laser. The results were calculated using the
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ments Ltd.). TiO2 was suspended in 0.45 lm MilliQ filtered water,
treated with ultrasound and measured in 1 ml disposable polystyrene
cuvettes. For calculations, we used the refractive (Ri) and absorption
indices (Rs) for rutile TiO2 (Ri =2 . 9 0 3 ;Rs = 0.100) and standard
properties for H2O. The density of TiO2 was set to 4.25 g⁄cm
3.
Immunization and airway challenge procedures. Mice (n = 7–8 per
group) were primarily immunized on day 0 with 1 lg OVA alone or
with 1 lg OVA in combination with either 2, 10, 50 or 250 lgT i O 2
intraperitoneal (i.p.). A group receiving 1 lg OVA in combination
with 270 lgA l ( O H ) 3 served as positive adjuvant control.
On days 13 and 20, all mice received a booster injection containing
0.1 lg OVA i.p. (fig. 1).
To avoid further particle agglomeration, the hydrous TiO2 suspen-
sion was diluted in sterile, pyrogen-free water as vehicle. Pyrogen-free
saline was used for booster injections where OVA was administered
without particles.
On days 27 and 34, all mice were challenged 20 min. with an aero-
sol of 1% OVA solution in saline.
The experiment was terminated on day 35. Blood samples were
collected by heart puncture followed by bronchoalveolar lavage
(BAL) as previously described [26].
Sera were assayed for content of OVA-specific IgE, IgG1 and
IgG2a. The measurement of IgE was performed using a commercial
IgE ELISA kit (OVA-IgE96 MD Biosciences, St Paul, MN, USA)
according to manufacturer’s description. IgG1 and IgG2a were
assayed as described previously [27]. Levels of interleukin (IL)-4,
IL-5, IL-10 and interferon (IFN)-c in BAL fluids were assayed by
ELISA kits (eBioscience, San Diego, CA, USA) according to manu-
facturer’s description.
Statistics. Antibody levels, numbers of inflammatory cells and levels
of cytokines in BAL fluid in the four TiO2 groups were compared to
the OVA control group by the Kruskal–Wallis test. If a statistically
significant difference was apparent, the individual TiO2 groups were
further compared to the OVA control group by the Mann-Whitney’s
U-test. A p-value of less than 0.05 was considered statistically signifi-
cant. Calculations were performed using the Minitab Statistical Soft-
ware, Release 14 Xtra (Minitab Inc., State College, PA, USA).
Results
Characterization of particles.
Dynamic Laser Scatter analysis showed that the size spec-
trum of the ultrasound-treated TiO2 particles suspended in
MilliQ-filtered water was highly dominated by nano-sized
particles (fig. 2). In the number size distribution, showed a
single modal peak occurred around 28 nm. Plotted by vol-
ume, a polymodal size distribution with coarser submicron
particles was resolved giving an average zeta-size of
140.04 € 1.36 nm (Polydispersivety Index: 0.22). However,
even by volume, more than 50% of the particles were smaller
than 100 nm. This is in agreement with the manufacturer’s
specification claiming that the mean aggregate size (d-50)
was below 100 nm.
The surface area of the particles was calculated to be
34.1 m
2⁄g.
OVA-specific antibodies in serum.
The IgE and IgG1 levels in the three lower doses of TiO2
were not statistically different from the OVA control group.
The highest dose of TiO2,2 5 0lg, gave rise to significantly
increased levels of IgE and IgG1 compared to the OVA con-
trol group (fig. 3). The Al(OH)3 adjuvant group gave rise to
a significantly higher level of IgG1, whereas the increase in
IgE was not statistically significant compared to the OVA
control group. Furthermore, the level of IgE, but not IgG1
was significantly higher in the 250 lgT i O 2 when compared
to the Al(OH)3 group (p = 0.009).
Levels of IgG2a were below the limit of detection in all
samples (data not shown).
Inflammatory cells in BAL.
A significantly increased level of eosinophils, neutrophils
and lymphocytes were seen in both the 250 lgT i O 2 group
and the adjuvant control group when compared to the OVA
Fig. 1. The study protocol. For details, confer the Materials and
Methods section.
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Fig. 2. The hydrodynamic number and volume size distribution of
the photocatalytic TiO2 (0.05 mg⁄ml) suspended in MilliQ-filtered
water.
Fig. 3. Levels of OVA-specific antibodies in serum. The antibody
level is expressed as arbitrary concentration units for IgG1. For IgE
the concentration unit is lg⁄10 ml. Data are median values with
75th percentile of 7–8 mice. Statistically increased level of antibody
when compared to OVA control is shown as *p <0 . 0 5 o r
**p < 0.01.
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adjuvant control group and the 250 lgT i O 2 groups revealed
that the number of neutrophilswere significantly higher in the
adjuvant control group, whereas no difference was seen on
the numbers of eosinophils, lymphocytes and macrophages.
Cytokines in BAL supernatant.
The Kruskal-Wallis analyses revealed a significant difference
among groups in the levels of both the IL-4 (p = 0.032) and
IL-5 (p = 0.002) (confer fig. 5); the highest levels of IL-4 and
IL-5 were seen in the 250 lgT i O 2 group and Al(OH)3
group. However, the pairwise comparison of exposure groups
with the OVA control groups revealed no significant differ-
ences, i.e. none of the individual exposure groups differed
from the OVA control group.
IL-10 and IFN-c were below the limits of detection in all
BAL samples (data not shown).
Discussion
Our study showed that the photocatalytic TiO2 nanoparticles
delivered as suspended in water possess adjuvant effect when
administered in combination with OVA in mice. The adju-
vant effect was suggested from the IgE and IgG1 levels, i.e.
TiO2 primes a Th2-dominant immune response. Photocata-
lytic TiO2 nanoparticles were significantly more potent than
Al(OH)3 to stimulate the IgE production, whereas the two
compounds gave rise to an approximately equal increase in
production of IgG1. Furthermore, TiO2 increased the influx
of inflammatory cells in the lung. The increased level of
eosinophils further supports that TiO2 stimulates an allergy-
related immune response. Administration of 250 lgT i O 2
gave rise to a 5-fold increase in the level of eosinophils, a
response comparable to that induced by 270 lgA l ( O H ) 3.A s
IgE is not significantly increased in the Al(OH)3 group, it
could be speculated that the eosinophilic inflammation
observed in this group is, at least in part, driven by the IgG1
antibody, which can be anaphylactic in the mouse after expo-
sure to high allergen levels [28,29].
The mechanisms behind the adjuvant effect of particles
have not been fully elucidated, but studies have shown that
the size of a particle is important for its adjuvant activity.
In general, adjuvanticity increases with decreasing particle
size [21,25]. Due to the higher specific surface area of nano-
particles as compared to micron-sized particles, more antigen
can be adsorbed to the same amount of particles [25]. Thus,
nano (below 30 nm in diameter) TiO2 particles were found
to bind more OVA per mass unit than fine (over 200 nm in
diameter) TiO2 particles [21]. This may lead to the formation
of an antigen depot with a prolonged release of antigen; a
process that may increase antigenicity. Adsorption of antigen
to a particle may also per se increase the antigenicity, as the
most important professional antigen presenting cell type, the
dendritic cells, are most effectively stimulated by antigen in
particulate form [30]. Another proposal for the adjuvant
mechanism is that ultra fine TiO2 may induce oxidative dam-
age and inflammation; processes that increase the level of
activity of immune competent cells. This is supported by an
unpublished study conducted at our institute (Dr. A.T.
Saber) showing that a single intratracheal instillation of
54 lg photocatalytic TiO2 nanoparticles induced acute neu-
trophilic inflammation in mice.
In conclusion, although micrometer-sized TiO2 particles in
general are considered to be biologically relatively inert, this
study has shown that TiO2 nanoparticles, which is a compo-
nent in e.g. self-cleaning products, has adjuvant effect in
mice. Thus, for TiO2, as shown for other substances, the toxi-
cological risk assessments based on fine particles may not
simply be extended to nanoparticles.
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